News/Updates
Structural Biology Related to HIV/AIDS MeetingJune 27–28, 2019
NIGMS Blog Post: Viral Views: New Insights on Infection Strategies
AIDS.gov
World Health Organization
U.S. Centers for Disease Control and Prevention
NIH's MedlinePlus
NIH's PubMed Health
NIH Office of AIDS Research
NIH’s National Institute of Allergy and Infectious Diseases
For more than 25 years, NIGMS has supported the structural characterization of human immunodeficiency virus (HIV) enzymes and viral proteins. This support has been instrumental in the development of crucial drugs for antiretroviral therapy such as protease inhibitors. NIGMS continues to support further characterization of viral proteins as well as cellular and viral complexes. These complexes represent the fundamental interactions between the virus and its host target cell and, as such, represent potential new targets for therapeutic development.
This page last reviewed on 3/8/2019 8:49 AM
